Comparative efficacy and acceptability of psychosocial interventions for individuals with cocaine and amphetamine addiction: A systematic review and network meta-analysis
- PMID: 30586362
- PMCID: PMC6306153
- DOI: 10.1371/journal.pmed.1002715
Comparative efficacy and acceptability of psychosocial interventions for individuals with cocaine and amphetamine addiction: A systematic review and network meta-analysis
Abstract
Background: Clinical guidelines recommend psychosocial interventions for cocaine and/or amphetamine addiction as first-line treatment, but it is still unclear which intervention, if any, should be offered first. We aimed to estimate the comparative effectiveness of all available psychosocial interventions (alone or in combination) for the short- and long-term treatment of people with cocaine and/or amphetamine addiction.
Methods and findings: We searched published and unpublished randomised controlled trials (RCTs) comparing any structured psychosocial intervention against an active control or treatment as usual (TAU) for the treatment of cocaine and/or amphetamine addiction in adults. Primary outcome measures were efficacy (proportion of patients in abstinence, assessed by urinalysis) and acceptability (proportion of patients who dropped out due to any cause) at the end of treatment, but we also measured the acute (12 weeks) and long-term (longest duration of study follow-up) effects of the interventions and the longest duration of abstinence. Odds ratios (ORs) and standardised mean differences were estimated using pairwise and network meta-analysis with random effects. The risk of bias of the included studies was assessed with the Cochrane tool, and the strength of evidence with the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach. We followed the PRISMA for Network Meta-Analyses (PRISMA-NMA) guidelines, and the protocol was registered in PROSPERO (CRD 42017042900). We included 50 RCTs evaluating 12 psychosocial interventions or TAU in 6,942 participants. The strength of evidence ranged from high to very low. Compared to TAU, contingency management (CM) plus community reinforcement approach was the only intervention that increased the number of abstinent patients at the end of treatment (OR 2.84, 95% CI 1.24-6.51, P = 0.013), and also at 12 weeks (OR 7.60, 95% CI 2.03-28.37, P = 0.002) and at longest follow-up (OR 3.08, 95% CI 1.33-7.17, P = 0.008). At the end of treatment, CM plus community reinforcement approach had the highest number of statistically significant results in head-to-head comparisons, being more efficacious than cognitive behavioural therapy (CBT) (OR 2.44, 95% CI 1.02-5.88, P = 0.045), non-contingent rewards (OR 3.31, 95% CI 1.32-8.28, P = 0.010), and 12-step programme plus non-contingent rewards (OR 4.07, 95% CI 1.13-14.69, P = 0.031). CM plus community reinforcement approach was also associated with fewer dropouts than TAU, both at 12 weeks and the end of treatment (OR 3.92, P < 0.001, and 3.63, P < 0.001, respectively). At the longest follow-up, community reinforcement approach was more effective than non-contingent rewards, supportive-expressive psychodynamic therapy, TAU, and 12-step programme (OR ranging between 2.71, P = 0.026, and 4.58, P = 0.001), but the combination of community reinforcement approach with CM was superior also to CBT alone, CM alone, CM plus CBT, and 12-step programme plus non-contingent rewards (ORs between 2.50, P = 0.039, and 5.22, P < 0.001). The main limitations of our study were the quality of included studies and the lack of blinding, which may have increased the risk of performance bias. However, our analyses were based on objective outcomes, which are less likely to be biased.
Conclusions: To our knowledge, this network meta-analysis is the most comprehensive synthesis of data for psychosocial interventions in individuals with cocaine and/or amphetamine addiction. Our findings provide the best evidence base currently available to guide decision-making about psychosocial interventions for individuals with cocaine and/or amphetamine addiction and should inform patients, clinicians, and policy-makers.
Conflict of interest statement
I have read the journal’s policy and the authors of this manuscript have the following competing interests: MJO is a consultant to Acadia Pharmaceuticals, Genomind, Johnson & Johnson/Janssen, Otsuka/Lundbeck, Sage Therapeutics, Sunovion, and Supernus Pharmaceuticals, and has received research funding from Palo Alto Health Sciences. All other authors have declared that no competing interests exist.
Figures
Similar articles
-
Psychosocial interventions for stimulant use disorder.Cochrane Database Syst Rev. 2024 Feb 15;2(2):CD011866. doi: 10.1002/14651858.CD011866.pub3. Cochrane Database Syst Rev. 2024. PMID: 38357958 Review.
-
Evaluating comparative effectiveness of psychosocial interventions adjunctive to opioid agonist therapy for opioid use disorder: A systematic review with network meta-analyses.PLoS One. 2020 Dec 28;15(12):e0244401. doi: 10.1371/journal.pone.0244401. eCollection 2020. PLoS One. 2020. PMID: 33370393 Free PMC article.
-
The future of Cochrane Neonatal.Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12. Early Hum Dev. 2020. PMID: 33036834
-
Cognitive-behavioural treatment for amphetamine-type stimulants (ATS)-use disorders.Cochrane Database Syst Rev. 2018 Dec 22;12(12):CD011315. doi: 10.1002/14651858.CD011315.pub2. Cochrane Database Syst Rev. 2018. PMID: 30577083 Free PMC article.
-
Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis.Lancet. 2018 Apr 7;391(10128):1357-1366. doi: 10.1016/S0140-6736(17)32802-7. Epub 2018 Feb 21. Lancet. 2018. PMID: 29477251 Free PMC article. Review.
Cited by
-
Barriers and facilitators to medication-assisted treatment for cocaine use disorder among men who have sex with men: a qualitative study.Addict Sci Clin Pract. 2024 Nov 20;19(1):84. doi: 10.1186/s13722-024-00515-0. Addict Sci Clin Pract. 2024. PMID: 39568074 Free PMC article. Clinical Trial.
-
A systematic review of treatment for impulsivity and compulsivity.Front Psychiatry. 2024 Sep 26;15:1430409. doi: 10.3389/fpsyt.2024.1430409. eCollection 2024. Front Psychiatry. 2024. PMID: 39391084 Free PMC article.
-
Methamphetamine dependence in Australia-why is 'ice' (crystal meth) so addictive?Psychiatr Psychol Law. 2023 Jul 4;31(4):671-704. doi: 10.1080/13218719.2023.2206870. eCollection 2024. Psychiatr Psychol Law. 2023. PMID: 39118784 Free PMC article.
-
Leveraging Parents and Peer Recovery Supports to Increase Recovery Capital in Emerging Adults With Polysubstance Use: Protocol for a Feasibility, Acceptability, and Appropriateness Study of Launch.JMIR Res Protoc. 2024 Jul 22;13:e60671. doi: 10.2196/60671. JMIR Res Protoc. 2024. PMID: 39037768 Free PMC article.
-
HIV and Substance Use Disorders.Infect Dis Clin North Am. 2024 Sep;38(3):599-611. doi: 10.1016/j.idc.2024.06.003. Epub 2024 Jul 2. Infect Dis Clin North Am. 2024. PMID: 38960783 Review.
References
-
- GBD 2016 DALYs and HALE Collaborators. Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390(10100):1260–1344. 10.1016/S0140-6736(17)32130-X - DOI - PMC - PubMed
-
- United Nations Office on Drugs and Crime. World drug report 2017. Vienna: United Nations Office on Drugs and Crime; 2017.
-
- Atkinson A, Anderson Z, Hughes K, Bellis MA, Sumnall H, Syed Q. Interpersonal violence and illicit drugs. Liverpool: Liverpool John Moores University Centre for Public Health; 2009 [cited 2018 May 24]. http://www.who.int/violenceprevention/interpersonal_violence_and_illicit....

